Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice
Frédérique Dol(Sanofi (France)), Jean‐Marc Herbert(Sanofi (France)), Anne-Marie Marés(Inserm), Jean‐Pierre Bidouard(Hôpital Lariboisière), Catherine Cazaubon(Institut Pasteur de Lille), Bart Staels(Inserm), Dino Nisato(Institut Pasteur de Lille), Geneviève Martin, Paul Schaeffer(Universidad La Salle), Philip Janiak(Hôpital Lariboisière)
Cited by 93
Related Papers
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901